Rekvina Laboratories Stock: price and insider trades · India
Rekvina Laboratories: what insiders have been doing
Rekvina Laboratories is a listed company. Its directors and officers file their transactions with SEBI (PIT + SAST). In the past year (8 November 2025 to 8 November 2026), 4 filings came from 4 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Compared with its exchange (1,984 companies, median 4 filings), a count of 4 filings is typical.
There has been no open-market purchase by an insider of Rekvina Laboratories for at least a year. Half of the filings or more reach the SEBI (PIT + SAST) feed on the day of the trade. This delay matters because a trade only becomes useful information once it is public.
These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 2,189,543 shares@ ₹10.007.02% mcap100.0% of flowEquityAllotmentSEBI:a1d9db758e5c96135847c3f1fa5fb54b032234e3
- 333,845 shares@ ₹10.001.07% mcap100.0% of flowEquityAllotmentSEBI:677cef593fda2b66629aff45b339236e4285a797
- 333,843 shares@ ₹10.001.07% mcap100.0% of flowEquityAllotmentSEBI:550abb185fa2d42b9fac1d2c43336fe3ddb4a4c5
- 2,099,820 shares@ ₹1.000.67% mcap100.0% of flowEquityAllotmentSEBI:a3581af5075567329b33eb3287c478adc61d0d6d
4 of 4 declarations
About Rekvina Laboratories
Rekvina Laboratories is a company operating in the XBOM market. It specializes in the development and production of innovative pharmaceutical solutions.